Literature DB >> 3553071

Effervescent ASA versus solid ASA in the treatment of tension headache. A double-blind, placebo controlled study.

M Langemark, J Olesen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3553071     DOI： 10.1111/j.1526-4610.1987.hed2702090.x

Source DB:  PubMed          Journal:  Headache        ISSN： 0017-8748            Impact factor:   5.887


× No keyword cloud information.
  7 in total

Review 1.  A review of the treatment of primary headaches. Part II: Tension-type headache.

Authors:  D D'Amico; L Grazzi; M Leone; F Moschiano; G Bussone
Journal:  Ital J Neurol Sci       Date:  1998-02

Review 2.  Aspirin for acute treatment of episodic tension-type headache in adults.

Authors:  Sheena Derry; Philip J Wiffen; R Andrew Moore
Journal:  Cochrane Database Syst Rev       Date:  2017-01-13

3.  Drug and Nondrug Treatment in Tension-type Headache.

Authors:  Lars Bendtsen
Journal:  Ther Adv Neurol Disord       Date:  2009-05       Impact factor: 6.570

4.  Population pharmacokinetics of fast release oral diclofenac in healthy volunteers: relation to pharmacodynamics in an experimental pain model.

Authors:  J Lötsch; B Kettenmann; B Renner; D Drover; K Brune; G Geisslinger; G Kobal
Journal:  Pharm Res       Date:  2000-01       Impact factor: 4.200

Review 5.  Current and potential future drug therapies for tension-type headache.

Authors:  Sait Ashina; Messoud Ashina
Journal:  Curr Pain Headache Rep       Date:  2003-12

6.  Tension-type Headache.

Authors:  Rigmor Jensen
Journal:  Curr Treat Options Neurol       Date:  2001-03       Impact factor: 3.972

7.  Italian guidelines for primary headaches: 2012 revised version.

Authors:  Paola Sarchielli; Franco Granella; Maria Pia Prudenzano; Luigi Alberto Pini; Vincenzo Guidetti; Giorgio Bono; Lorenzo Pinessi; Massimo Alessandri; Fabio Antonaci; Marcello Fanciullacci; Anna Ferrari; Mario Guazzelli; Giuseppe Nappi; Grazia Sances; Giorgio Sandrini; Lidia Savi; Cristina Tassorelli; Giorgio Zanchin
Journal:  J Headache Pain       Date:  2012-05       Impact factor: 7.277
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.